LitCovid-sentences  

PMC:7096774 / 17627-20503 JSONTXT 10 Projects

Annnotations TAB TSV DIC JSON TextAE

Id Subject Object Predicate Lexical cue
T140 0-16 Sentence denotes Acknowledgements
T141 17-244 Sentence denotes We gratefully thank Mira Utriainen, Sanna Mäki, Minna Haanpää, Marja-Liisa Ollonen, Johanna Rintamäki, Hanna Valtonen, Riitta Santanen, Katri Keino, Alena Kaijalainen and Johanna Mustajoki for their expert technical assistance.
T142 245-352 Sentence denotes Christel Pussinen and Mervi Nosa are thanked for their contribution to Finnish population sera collections.
T143 353-449 Sentence denotes We also want to thank the anonymous patient for her help and collaboration throughout the study.
T144 450-458 Sentence denotes Funding:
T145 459-614 Sentence denotes The study was supported by funds from the Finnish Institute for Health and Welfare (THL), Helsinki University Hospital (HUSLAB) and University of Helsinki.
T146 615-757 Sentence denotes The funding organisations had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.
T147 759-902 Sentence denotes Conflict of interest: LS is a co-investigator in an unrelated study, for which THL has received research funding from GlaxoSmithKline Vaccines.
T148 903-963 Sentence denotes The other authors report no potential conflicts of interest.
T149 964-987 Sentence denotes Authors’ contributions:
T150 988-1051 Sentence denotes All authors attest they meet the ICMJE criteria for authorship.
T151 1052-1139 Sentence denotes All authors have contributed to, seen and approved the final version of the manuscript.
T152 1140-1343 Sentence denotes AH set up and performed MN tests, participated in laboratory confirmation of COVID-19 suspicions, coordinated and participated in the collections of the Finnish population sera, and wrote the manuscript.
T153 1344-1414 Sentence denotes TS performed the whole genome sequencing and genetic characterisation.
T154 1415-1473 Sentence denotes SK and JH performed the IFA and WB analysis, respectively.
T155 1474-1583 Sentence denotes PÖ isolated the virus and was responsible of the SARS-CoV-2 related biosafety level 3 laboratory work at THL.
T156 1584-1670 Sentence denotes MP, MS, TP and JS participated in THL COVID-19 situation monitoring group work of THL.
T157 1671-1740 Sentence denotes SB and MM participated in serological analysis planning group of THL.
T158 1741-1792 Sentence denotes SB contributed in the interpretation of MN results.
T159 1793-1905 Sentence denotes ER set up the real-time RT-PCR method at THL and participated in laboratory confirmation of COVID-19 suspicions.
T160 1906-1969 Sentence denotes AK and TS participated in collection of the convalescent serum.
T161 1970-2038 Sentence denotes AK had a significant role to organising convalescent serum sampling.
T162 2039-2124 Sentence denotes HKK, LM and ML were in charge of primary diagnostic of COVID-19 suspicions in HUSLAB.
T163 2125-2253 Sentence denotes HKK and LM also set up the real-time RT-PCR method at HUSLAB and participated in laboratory sample logistics from HUSLAB to THL.
T164 2254-2313 Sentence denotes MB was responsible for the care of the patient in hospital.
T165 2314-2388 Sentence denotes MJ and LS participated in interviewing the index case and contact tracing.
T166 2389-2572 Sentence denotes OV was responsible for virological and serological studies in HUSLAB and University of Helsinki, participated in the designing of the study and organising convalescent serum sampling.
T167 2573-2752 Sentence denotes NI and CSK were responsible of THL laboratory confirmation of COVID-19 suspicions, participated in COVID-19 situation monitoring group work of THL and laboratory sample logistics.
T168 2753-2876 Sentence denotes CSK was also responsible for the collections of the Finnish population sera and participated in the designing of the study.